Find News

Filter articles

Applied Filters

Showing 41 to 50 of 642 results

CMA accuses 4 pharma companies of anti-competitive conduct


Four pharmaceutical companies allegedly agreed not to compete for the supply of an anti-nausea tablet to the National Health Service, according to objections filed by the UK Competition and Markets Authority.

E+F patent attorney elevated to partner


Elkington + Fife has unveiled Mark Scott as a new partner in the UK firm’s patent practice.

Novartis to boost eye care portfolio with $3.4bn buy


Novartis is set to acquire assets associated with Xiidra ((lifitegrast ophthalmic solution), a dry eye treatment, from Takeda.

NHS partners with drugmakers to eliminate hep C


The National Health Service, the UK’s government-run health system, has partnered with Gilead Sciences, Merck Sharp and Dohme and AbbVie to help eliminate hepatitis C in England.

AstraZeneca partners on AI drug discovery collaboration


AstraZeneca has begun collaborating with UK-headquartered artificial intelligence company BenevolentAI to use AI and machine learning for the discovery and development of new treatments.

EU complains to WTO over Turkey’s pharma measures

EU, Turkey11-04-2019

The European Union has asked the World Trade Organization to initiate dispute consultations with Turkey over requirements imposed by the country on pharmaceutical products.

EPO president refers plant patentability decision for appeal


European Patent Office president António Campinos will refer a recent decision on the patentability of exclusively obtained by essentially biological processes to the office’s Enlarged Board of Appeal.

Eli Lilly defeat shows one size does not fit all in obviousness test: lawyers


The UK Supreme Court’s decision in Actavis v Eli Lilly confirms that a multi-factorial judgement should be used to determine whether an invention is obvious or not, lawyers have told WIPR.

Cancer Research UK forms immunotherapy alliance


Cancer Research UK has formed a multimillion-pound drug discovery alliance with fellow charity LifeArc and Japanese company Ono Pharmaceutical.

UK biotech R&D up 65% since 2016, says report


A “biotech boom” is underway in the UK, according to a new report from UK investment management firm Downing.

Showing 41 to 50 of 642 results